83bar Further Expands Global Patient Activation Capabilities
ncarol.com/10034101

AUSTIN, Texas - ncarol.com -- 83bar has announced continued global expansion of its patient activation capabilities in Europe, through a combination of strategic partnerships and management assignments.

According to Bob Baurys, CEO of 83bar, the company will provide clinical study enrollment and patient recruitment services through the 83bar contact center. This is in addition to the company doubling capacity of its clinical contact center with additional nurses in the United States.

83bar has created a fully integrated digital health technology and concierge platform that enables individualized patient activation at scale. The company already has achieved dramatic growth with its process. With this strategic expansion, 83bar will grow its global contact center to educate prospective patients on clinical study details, qualify patients based on health history, use empathic communication skills, and assist in navigating the patient along the pathway to enrollment.

More on ncarol.com

• 15,000+ Fans Expected at the 2026 BIG HBCU Southern Classic Battle of the Bands in Charlotte
• Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
• Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
• America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
• Railinc Launches RIGIS Routing+Mileage Application to Provide Accurate & Comprehensive Rail Routing

"We're excited about the greater international reach of our platform for patient outreach and clinical trial recruitment," says Baurys. "We are already achieving meaningful results for clients of marketed medical products, plus clinical study sponsors, investigator sites, and most of all, for patients."

The 83bar platform currently serves more than 50 healthcare clients and hundreds of physician practices and clinical trial sites worldwide.

Jerry Furness, vice president of client services at 83bar, has spearheaded the global operations expansion. Furness says, "Our client partners have seen how the four-part Patient Activation system helps build a predictable pathway that allows them to measure ROI. Now, we're pleased to not only scale the system to new markets, but also add multiple language capabilities for more patients to access."

Baurys adds, "The focus is to continue improving the quality of the patient experience and fulfill the real-world potential for clients' treatments. Every new market we move into will help demonstrate that potential even more."

More on ncarol.com

• FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
• BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
• "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
• Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
• Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand

About 83bar, LLC

83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system that has been implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is a system integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com